Overview consensus statement-Reference-Cited by-同舟云学术

Overview consensus statement

Published:2002-09 Issue:3 Volume:60 Page:1-6
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Carroll Peter R,Kantoff Philip W,Balk Steven P,Brown Myles A,D’amico Anthony V,George Daniel J,Grossfeld Gary D,Johnson Candace S,Kelly William Kevin,Klotz Laurence,Lee W.Robert,Lubeck Deborah P,Mcleod David G,Oh William K,Pollack Alan,Sartor Oliver,Smith Matthew R,Hart Carol

Publisher

Elsevier BV

Subject

Urology

Reference3 articles.

1. Phase III Radiation Therapy Oncology Group (RTOG) 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate;Pilepich;Int J Radiat Oncol Biol Phys,2001

2. Updated results of the phase III Radiation Therapy Oncology Group (RT) trial 8531 evaluating the potential benefit of androgen suppression therapy following standard radiation therapy for unfavorable prognosis prostate cancer;Lawton;Int J Radiat Oncol Biol Phys,2001

3. Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy;Bolla;Eur J Cancer,1999

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer;Nuclear Medicine Communications;2014-01

2. Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC);BJU International;2013-04-12

3. Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells;The Prostate;2013-02-19

4. A panel of five circulating microRNAs as potential biomarkers for prostate cancer;The Prostate;2012-02-01

5. Synergistic antimicrotubule therapy for prostate cancer;Biochemical Pharmacology;2011-02